Literature DB >> 17629395

Minimally invasive treatment of ureteropelvic junction obstruction: a critical analysis of results.

Christopher G Eden1.   

Abstract

OBJECTIVES: To analyse the indications and long-term results of endoscopic and minimal access approaches for the treatment of ureteropelvic junction (UPJ) obstruction and to compare them to open surgery.
METHODS: A review of the literature from 1950 to January 2007 was conducted using the Ovid Medline database.
RESULTS: A lack of standardisation of techniques used to diagnose UPJ obstruction and to follow up treated patients introduces a degree of inaccuracy in interpreting the success rates of the various modalities of treatment. However, there is no indication that any one of these techniques is affected by this to a greater or lesser extent than another. Open pyeloplasty achieves very good (90-100% success) results, endopyelotomy and balloon disruption of the UPJ fail to match these results by 15-20%, and minimal access pyeloplasty produces results that are at least as good as those of open surgery but with the advantages of a minimal access approach.
CONCLUSIONS: Minimal access pyeloplasty is likely to gradually replace endopyelotomy and balloon disruption of the UPJ for the treatment of UPJ obstruction. The much higher cost of robotic pyeloplasty and greater availability of laparoscopic expertise in teaching centres are likely to limit the dissemination of robotic pyeloplasty.

Entities:  

Mesh:

Year:  2007        PMID: 17629395     DOI: 10.1016/j.eururo.2007.06.047

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  21 in total

1.  [Pyeloplasty - pro robotic-assisted].

Authors:  Z Akçetin; S Siemer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  Initial experiences with laparoscopy and flexible ureteroscopy combination pyeloplasty in management of ectopic pelvic kidney with stone and ureter-pelvic junction obstruction.

Authors:  Zhuo Yin; Y B Wei; B L Liang; K Q Zhou; Y L Gao; B Yan; Z Wang; J R Yang
Journal:  Urolithiasis       Date:  2015-02-10       Impact factor: 3.436

Review 3.  Ureteropelvic obstruction and renal stones: etiology and treatment.

Authors:  Andreas Skolarikos; Andreas Dellis; Thomas Knoll
Journal:  Urolithiasis       Date:  2014-11-02       Impact factor: 3.436

Review 4.  Pelvi-ureteric junction obstruction related to crossing vessels: vascular anatomic variations and implication for surgical approaches.

Authors:  Frédéric Panthier; Fabien Lareyre; Marie Audouin; Juliette Raffort
Journal:  Int Urol Nephrol       Date:  2018-01-04       Impact factor: 2.370

5.  A prospective randomised comparison between the transperitoneal and retroperitoneoscopic approaches for robotic-assisted pyeloplasty in a single surgeon, single centre study.

Authors:  Wael Y Khoder; Raphaela Waidelich; Abdel Majeed Al Ghamdi; Therese Schulz; Armin Becker; Christian G Stief
Journal:  J Robot Surg       Date:  2017-05-22

6.  [Pyeloplasty: pro laparoscopic].

Authors:  P Bader
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

7.  Laparoscopic pyeloplasty: an analysis of first 100 cases and important lessons learned.

Authors:  Onkar Singh; Shilpi Singh Gupta; Nand Kishore Arvind
Journal:  Int Urol Nephrol       Date:  2010-05-21       Impact factor: 2.370

8.  Outcomes of robot-assisted laparoscopic transperitoneal pyeloplasty procedures: a series of 18 patients.

Authors:  Kemal Ener; Serkan Altınova; Abdullah Erdem Canda; Muhammet Fuat Özcan; Erem Asil; Emre Ürer; Ali Fuat Atmaca; Ziya Akbulut
Journal:  Turk J Urol       Date:  2014-12

9.  Laparoscopic dismembered pyeloplasty: technique and results in 105 patients.

Authors:  Sigrid Wagner; Francesco Greco; Antonino Inferrera; M Raschid Hoda; Felix Kawan; Amir Hamza; Paolo Fornara
Journal:  World J Urol       Date:  2009-10-22       Impact factor: 4.226

Review 10.  Complications of laparoscopic pyeloplasty.

Authors:  Jens J Rassweiler; Dogu Teber; Thomas Frede
Journal:  World J Urol       Date:  2008-05-10       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.